Olympus Shares Plunge After FDA Warning Letter on Six Facilities

Olympus Corp. shares tumbled the most since April 2025 after the U.S. Food and Drug Administration issued a warning letter to the Japanese medical device maker following inspections at six facilities. The FDA's action raises concerns about compliance and potential impact on Olympus's U.S. operations.